Effect of Angiotensin Converting Enzyme Inhibitor, Lisinopril, on Renal Blood Flow and Its Correlation With Proteinuria Reduction in Subjects With Type 2 Diabetes and Kidney Disease
Stopped early · Not applicable
Conditions studied: Type 2 Diabetes
In brief
The purpose of the study is to investigate the effect of a blood pressure medication, Lisinopril, or similar drugs in that class, on the flow of blood to the kidneys. In this study, we will compare blood flow to the kidneys in healthy people that do not have diabetes or kidney disease with people that have diabetes and evidence of kidney disease.
Key facts
- Study ID
- NCT01101269
- Run by
- University of Virginia
- People needed
- 6
- Starts
- 2010-02-01
- Expected to finish
- 2014-12-01
- Last updated by the study team
- 2017-05-12
Who can join
Age: 40 and older, up to 75. Sex: any. Healthy volunteers: accepted.
Where it is running
- University of Virginia Health System — Charlottesville, Virginia, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.